tirzepatide and warfarin Can be used safely in a patient with factor V Leiden thrombophilia, type 2 diabetes (or obesity), stable anticoagulation? Tirzepatide ODT | Empower Pharmacy

Emerging GLP-1 benefits being studied Newer research suggests GLP-1 drugs may have effects beyond blood sugar control, appetite and weight loss

Multiple themes with light and dark mode support to suit everyones preferences

Recently, medical research and breakthroughs have introduced some very promising medications that have been shown to give patients a more consistent response in possible weight loss management

Beyond traditional hair transplants, innovative treatments like exosomes therapy and Platelet-Rich Plasma (PRP) therapy are revolutionizing how we approach hair loss treatment in NYC

SURMOUNT-1 data show that 48% of patients on 15mg maintenance experienced nausea, 29% experienced diarrhea, 24% experienced vomiting, and 19% experienced constipation during the first four weeks at peak dose